TADESO Unveils a New Approach to Skin Health in the Philippines with the Launch of DWA-AT and Skin Atoz from Korea
Filipino pharmaceutical company aims to restore everyday relief to Filipinos battling chronic dermatological conditions by introducing Korean medical innovations to the country.
MANILA, PHILIPPINES — 18 September 2026 — Filipino pharmaceutical company TADESO Pharmaceutical Ventures, Inc. is bringing a new perspective to skin health with the launch of two of its key products, DWA-AT (Dermatitis Wiped Away–Atopic Therapeutic) and Skin Atoz (Skin Allergen Treatment Optimum Zeal), at a special media and product unveiling event at Luxent Hotel, Timog Avenue, Quezon City.
Hosted by veteran host, actor, entrepreneur and author RJ Ledesma together with Supermodel Universe International 2025, Founder of Asia World Fashion Week and Versa, Ms. Yna Uy, the launch introduces TADESO and its vision of providing targeted dermatological solutions for people dealing with challenging and persistent skin concerns.
At the heart of the company's launch is a simple proposition: skin care should be about more than hiding imperfections—it should be about helping people feel comfortable, confident and cared for in their own skin.
TADESO defines its name as Targeted Dermatological Solutions—a philosophy centered on understanding specific skin concerns, identifying their needs and delivering solutions designed for compromised skin.
From a personal struggle to a pharmaceutical venture
For TADESO founder and CEO Dra. Ria Dela Cruz, the company's beginnings are deeply personal.
“No More Hiding — Unmask. Heal.”
Having grown up highly dependent on steroid medications because of asthma and allergies, Dra. Dela Cruz later developed eczema herself. Her search for a way to manage recurring flare-ups continued for approximately 13 years before her journey led her to DWA-AT.
Her experience became part of the motivation behind TADESO: to explore solutions for people who, like her, have struggled with chronic skin concerns and have often found themselves searching for alternatives.
The founder's story reflects a larger purpose for the company—to explore the potential of natural ingredients and combine them with science and innovation to create healthcare solutions that people can trust.
TADESO aims to be a bridge between conventional cosmetic skin care and a more science-driven approach to skin health. Through its products, the company hopes to help people move beyond hiding the skin they have learned to conceal – to experience healing, regain confidence and rediscover the freedom to show their skin as it is. Because when healing begins, there should be No More Hiding.
DWA-AT: Targets eczema, psoriasis and atopic dermatitis
Leading the launch is DWA-AT, a targeted therapeutic product for skin concerns including eczema, psoriasis and atopic dermatitis. DWA-AT contains glycerol, tannin, honey and herbal extract and is formulated without steroids and paraben. It’s formulation is designed to support skin regeneration and the skin's natural barrier.
Skin Atoz: Targeted care for sensitive and compromised skin
Joining DWA-AT at the launch is Skin Atoz, a lotion for skin irritations including burns, atopic dermatitis, rashes and post-laser treatment.
Skin Atoz is steroid-free, antihistamine-free and paraben-free, with natural ingredients including glycerol, honey and herbal extract, together with carbomer. The product is a moisturizer intended to support the healing process and help calm redness.
Together, DWA-AT and Skin Atoz form part of TADESO's broader wound-care and dermatological product portfolio, alongside other products addressing a range of wound and skin concerns.
Science, accessibility and the human side of skin health
While the launch highlights Korean dermatological innovation and science, TADESO's mission goes beyond technology.
The company believes that medical innovation matters only when people can actually access it. They therefore place emphasis not only on product development, but also on expanding distribution and making its products more accessible through online, brick-and-mortar and digital partners. To ensure the quality assurance TADESO is committed to delivering, all products are FDA-approved and are supported by scientific studies. Clinically formulated to meet rigorous global healthcare benchmarks, Tadeso’s advanced therapeutic line has successfully passed international quality and safety standards to ensure trusted, patient-first formulations.
Dra. Dela Cruz describes the company's aspiration as becoming more than a pharmaceutical company, “we want people to experience hope, confidence and the feeling that they are not alone in their skin journey.”
A new conversation about skin health
The September 18 launch brings together members of the media, healthcare community, business partners and other stakeholders for the unveiling of TADESO and its flagship products.
The program features presentations from TADESO leadership and product representatives, including CEO Dra. Ria Dela Cruz and Head of Sales and Marketing, Ms. Janet Palmenco, followed by the opportunity for members of the media to ask questions and learn more about the company's products, direction and vision.
Dra. Johanna O. Ojeda, whose background is in Aesthetic Medicine, served as a resource speaker to explain the leading causes of these skin disorders and the dual physical and emotional toll they take on patients.
Guests have an opportunity to experience the products firsthand with special raffle prizes also in store.
Comments